Utilization of “Diet Drugs” is Skyrocketing. How Will it Impact Employee Benefit Plans?
Employers have recently seen a significant increase in healthcare spend within the metabolic/weight loss management category due to the promotion of new “diet drugs” such as Wegovy, Ozempic and Mounjaro. […]